Please login to the form below

Not currently logged in
Email:
Password:

Avastin off-licence

This page shows the latest Avastin off-licence news and features for those working in and with pharma, biotech and healthcare.

Bayer to challenge Avastin legal ruling

Bayer to challenge Avastin legal ruling

England’s use of Avastin is not an isolated one. Health systems in other countries, including France, have also promoted its off-licence use, with a number of publicly-funded trials ... Switching to off-licence Avastin would save £100m or more, if

Latest news

  • UK doctors call on NHS to use Avastin for wet AMD UK doctors call on NHS to use Avastin for wet AMD

    drug Avastin 'off- licence' to treat wet age-related macular degeneration (AMD). ... Asking Simon Stevens at NHS England to support the case for change and to support clinical commissioners who wish to make local commissioning decisions to prescribe

  • UPDATE: Greater Manchester PCTs react to Avastin off-licence use

    UPDATE: Greater Manchester PCTs react to Avastin off-licence use. The Association of Greater Manchester PCTs releases a statement following reports in the Guardian yesterday that doctors were prescribing Avastin ... The association of Greater Manchester

  • NHS may permit off-licence use of Avastin in wet-AMD

    NHS may permit off-licence use of Avastin in wet-AMD. According to a Guardian newspaper report, NHS doctors are planning to give patients with wet-AMD a similar drug that ... Some doctors have reported promising results from using Avastin on an

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics